• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
LeadershipLeadership Next

Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved

By
McKenna Moore
McKenna Moore
Down Arrow Button Icon
By
McKenna Moore
McKenna Moore
Down Arrow Button Icon
October 27, 2020, 5:30 AM ET
Leadership Next podcast with Sanofi CEO Paul Hudson.
Sanofi CEO Paul HudsonStuart Isett for Fortune

On the latest episode of Leadership Next, Fortune’s podcast about the changing role of business leadership, Sanofi CEO Paul Hudson tells cohosts Alan Murray and Ellen McGirt that he thinks it’s a great time to be a CEO. Despite the turmoil corporations have been thrust into in 2020, from navigating the coronavirus pandemic to trying to weather its subsequent economic downturn, Hudson says there is a great honor in heading a company in this era. 

“I’m privileged to be leading an organization that has got 10,000 people in our vaccines group who are right now working seven days a week to try and bring something to help the entire planet,” he says. “How could I not feel the responsibility and privilege of that?” 

The French pharmaceuticals company has two vaccine candidates for COVID-19, the disease caused by the virus that has attacked millions around the world. Hudson, who has been CEO for just over a year, says that the company’s long history of producing huge numbers of vaccines for everything from polio to influenza each year has positioned it to innovate with efficiency. But he’s not going to be upset if Sanofi loses the race to a vaccine, he says, because the world needs one as soon as possible. 

That good-natured outlook isn’t typical in Big Pharma, Murray points out around the 7:15 mark, but the pandemic has encouraged the industry to work together in a way no one has seen in modern history. And Hudson thinks it’s going to stick around even after a COVID-19 vaccine is approved and distributed, as the pharmaceuticals industry returns to tackling treatments for diseases like Parkinson’s and early stage breast cancer. And while competition spurs innovation, cooperation could lead to even bigger breakthroughs in the world of medicine. 

“How we’re changing the way we work in our company and the things that we’ll want to keep after the crisis is the same as the work outside of our company with our partners, other companies, stakeholders,” he said. “I think the collaborative spirit will stay.” 

More must-read stories from Fortune:

  • What business needs from the 2020 election
  • The World’s 25 Best Workplaces
  • 2020’s Most Powerful Women in business
  • The Most Powerful Women in business outside the U.S.
  • The holidays used to be UPS’s busiest time. Then came COVID-19

About the Author
By McKenna Moore
Twitter icon
See full bioRight Arrow Button Icon

Latest in Leadership

Nicholas Thompson
C-SuiteBook Excerpt
I took over one of the most prestigious media firms while training for an ultramarathon. Here’s what I learned becoming CEO of The Atlantic
By Nicholas ThompsonDecember 13, 2025
8 hours ago
Lauren Antonoff
SuccessCareers
Once a college dropout, this CEO went back to school at 52—but she still says the Gen Zers who will succeed are those who ‘forge their own path’
By Preston ForeDecember 13, 2025
9 hours ago
Asiathe future of work
The CEO of one of Asia’s largest co-working space providers says his business has more in common with hotels
By Angelica AngDecember 12, 2025
17 hours ago
Donald Trump
HealthHealth Insurance
‘Tragedy in the making’: Top healthcare exec on why insurance will spike to subsidize a tax cut to millionaires and billionaires
By Nick LichtenbergDecember 12, 2025
24 hours ago
three men in suits, one gesturing
AIBrainstorm AI
The fastest athletes in the world can botch a baton pass if trust isn’t there—and the same is true of AI, Blackbaud exec says
By Amanda GerutDecember 12, 2025
1 day ago
Brainstorm AI panel
AIBrainstorm AI
Creative workers won’t be replaced by AI—but their roles will change to become ‘directors’ managing AI agents, executives say
By Beatrice NolanDecember 12, 2025
1 day ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
22 hours ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple CEO Tim Cook out-earns the average American’s salary in just 7 hours—to put that into context, he could buy a new $439,000 home in just 2 days
By Emma BurleighDecember 12, 2025
1 day ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.